Cargando…

CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)

Detalles Bibliográficos
Autores principales:	Khan, SN, DaSilva, C, Renella, P, Satou, G, Ayad, I, Patel, S, Boechat, I, Finn, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Workshop Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560090/ http://dx.doi.org/10.1186/1532-429X-15-S1-W32

Ejemplares similares

CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)
por: Khan, Sarah N, et al.
Publicado: (2013)

Cardiac MR imaging and MR angiography in pediatric congenital heart disease: a comparison between 1.5T and 3.0T
por: Nguyen, KL, et al.
Publicado: (2013)

Comparison of Gadopentetate dimeglumine and Gadobenate dimeglumine in depiction of non-ischemic fibrosis in hypertrophic cardiomyopathy
por: Rudolph, Andre, et al.
Publicado: (2009)

Neurotoxic Manifestations of an Overdose Intrathecal Injection of Gadopentetate Dimeglumine
por: Park, Kwan-Woong, et al.
Publicado: (2010)

Contrast enhanced magnetic resonance angiography in children: initial experience at 3.0 Tesla
por: Khan, SN, et al.
Publicado: (2013)

Single dose gadobenate dimeglumine for imaging chronic of myocardial infarction in comparison to double dose gadopentetate dimeglumine
por: Bauner, Kerstin U, et al.
Publicado: (2009)

Lack of nephrotoxicity of gadopentetate dimeglumine-enhanced non-vascular MRI and MRI without contrast agent in patients at high-risk for acute kidney injury
por: Oguz, Ebru Gok, et al.
Publicado: (2013)

Visualization of Chronic Myocardial Infarction Using the Intravascular Contrast Agent MS-325 (Gadofosveset) in Patients
por: Thouet, Thomas, et al.
Publicado: (2012)

A Comparison between Gadofosveset Trisodium and Gadobenate Dimeglumine for Steady State MRA of the Thoracic Vasculature
por: Camren, G. Paul, et al.
Publicado: (2014)

Comparison of gadoxetic acid and gadopentetate dimeglumine-enhanced MRI for HCC detection: prospective crossover study at 3 T
por: Besa, Cecilia, et al.
Publicado: (2015)

A case report of gadopentetate dimeglumine‐induced cardiac arrest: Resuscitation using extracorporeal membrane oxygenation
por: Fang, Honglong, et al.
Publicado: (2023)

Correlations from gadopentetate dimeglumine-enhanced magnetic resonance imaging after methotrexate chemotherapy for hemorrhagic placenta increta
por: Wehbe, Salim A, et al.
Publicado: (2003)

Myocardial T1 mapping and determination of partition coefficients at 3 tesla: comparison between gadobenate dimeglumine and gadofosveset trisodium
por: Nacif, Marcelo Souto, et al.
Publicado: (2018)

Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model
por: Wang, Shu-ting, et al.
Publicado: (2019)

CMR in pediatric patients with congenital heart disease: comparison at 1.5T and at 3.0T
por: Nguyen, Kim-Lien, et al.
Publicado: (2012)

Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017)
por: Ding, Ying, et al.
Publicado: (2018)

Gadobenate Dimeglumine as an Intrabiliary Contrast Agent: Comparison with Mangafodipir Trisodium with Respect to Non-dilated Biliary Tree Depiction
por: Lim, Joon Seok, et al.
Publicado: (2005)

Gadofosveset-enhanced magnetic resonance angiography
por: Goyen, Mathias
Publicado: (2008)

(18) F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine
por: Kirchner, Julian, et al.
Publicado: (2017)

Multiple reader comparison of 2D TOF, 3D TOF, and CEMRA in screening of the carotid bifurcations: Time to reconsider routine contrast use?
por: Ross, Jeffrey S., et al.
Publicado: (2020)

High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol
por: Shahrouki, Puja, et al.
Publicado: (2021)

High-field MR imaging in pediatric congenital heart disease: Initial results
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Gadobutrol versus gadofosveset-trisodium in MR venography of the lower extremities
por: Arnoldussen, Carsten W. K. P., et al.
Publicado: (2017)

Severe Adverse Drug Reaction to Gadobenate Dimeglumine
por: Singer, Benjamin D., et al.
Publicado: (2009)

Gadofosveset trisodium in coronary magnetic resonance angiography at 3 Tesla
por: Raman, Fabio S, et al.
Publicado: (2014)

Overcoming the Low Relaxivity of Gadofosveset at High Field with Spin Locking
por: Richardson, O C, et al.
Publicado: (2012)

MRI with gadofosveset: A potential marker for permeability in myocardial infarction
por: Lavin, Begoña, et al.
Publicado: (2018)

The Unusual Suspect: Gadobenate-Dimeglumine Induced Kounis Syndrome
por: Choudhry, Faiza, et al.
Publicado: (2019)

CMR Assessment of endothelial damage and angiogenesis in porcine coronary arteries using gadofosveset
por: Pedersen, Steen F, et al.
Publicado: (2011)

Nebulized liposomal gadobenate dimeglumine contrast formulation for magnetic resonance imaging of larynx and trachea
por: Wei, Xiaohui, et al.
Publicado: (2011)

Towards Endometriosis Diagnosis by Gadofosveset-Trisodium Enhanced Magnetic Resonance Imaging
por: Schreinemacher, Marc H., et al.
Publicado: (2012)

Optimization of gadofosveset intravenous injection scheme for coronary MRA: the pharmacokinetics approach
por: Ahlman, Mark A, et al.
Publicado: (2014)

Use of carbon dioxide as an intravascular contrast agent: A review of current literature
por: Ali, Fahad, et al.
Publicado: (2017)

Methemoglobin Modulation as an Intravascular Contrast Agent for Magnetic Resonance Imaging: Proof of Concept
por: McNally, J. Scott, et al.
Publicado: (2019)

Automated coronary artery tracking in contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0T
por: Dey, D, et al.
Publicado: (2013)

Iopromide- and gadopentetic acid-derived preparates used in MR arthrography may be harmful to chondrocytes
por: Oznam, Kadir, et al.
Publicado: (2017)

WORKSHOPS 7–9: Wednesday 18 October 2006, 11:30–13:00
Publicado: (2006)

WORKSHOPS 1–3: Monday 16 October 2006, 16:00–17:30
Publicado: (2006)

WORKSHOPS 4–6: Tuesday 17 October 2006, 16:00–17:30
Publicado: (2006)

Gadofosveset-Based Biomarker of Tissue Albumin Concentration: Technical Validation in Vitro and Feasibility in Vivo
por: Richardson, Owen C, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4eqop57s2g7jvshffesvtrj9ct